Results

Experienced in corporation formation, P&L management, regulatory approval plans, and business function outsourcing. Proven track record of executing FDA approvals, launching digital platforms, managing commercial affairs, executing global launch strategies, and driving organizational growth that achieve substantial revenue gains. 

Led numerous high-impact strategic projects by deploying consultative guidance, innovative methodologies, established processes, and subject matter expertise. These initiatives played a pivotal role in successfully launching programs, solutions, and technologies, leading to improved outcomes, heightened patient satisfaction, reduced healthcare costs, and increased company revenues.

Developed, created, and implemented a multitude of Executive Partnerships, Value-Based, and Creative contract agreements, resulting in increased revenues, safeguarded against price erosion, and effectively disrupted competitive threats. Collaborated with the largest west coast healthcare systems to enhance clinical outcomes, broaden access to care, and optimize operational efficiencies.

Team successfully secured new 5-year partnership agreements with the two largest payer customers, totaling over $40 million.

Successfully negotiated contracts totaling over $40 million with the largest payer and care delivery organizations in the United States.

The 100 million dollar region achieved impressive results, delivering greater than 10 percent year-over-year revenue and market share growth. It earned the top rank among 35 United States Regions.

Led the United States sales teams in business development, resulting in the expansion of annual revenue by over 10 percent, reaching $50 million.

Selected as one of 15 individuals to initiate a start-up organization, contributing to its remarkable growth from $500,000 to $56 million within a 5-year timeframe.

Created, launched, and executed the go-to-market approach for new innovative virtual care platforms, artificial intelligence solutions, and next-generation technologies. This strategic initiative aimed to expand a $1 billion United States business into new acute care markets, employing value-based contracting and a population health approach.